(19)
(11) EP 2 054 416 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
16.07.2014 Bulletin 2014/29

(45) Mention of the grant of the patent:
05.01.2011 Bulletin 2011/01

(21) Application number: 07788196.9

(22) Date of filing: 03.08.2007
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
(86) International application number:
PCT/EP2007/058060
(87) International publication number:
WO 2008/015269 (07.02.2008 Gazette 2008/06)

(54)

SUBSTITUTED PYRAZOLOPYRIMIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINE

SUBSTITUIERTE PYRAZOLOPYRIMIDINE, EIN VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIZIN

PYRAZOLOPYRIMIDINES SUBSTITUÉES, PROCÉDÉ DE PRÉPARATION ET D'UTILISATION DE CELLES-CI EN TANT QUE MÉDICAMENTS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 04.08.2006 US 835820 P
28.12.2006 US 877544 P

(43) Date of publication of application:
06.05.2009 Bulletin 2009/19

(60) Divisional application:
10190596.6 / 2295439

(73) Proprietor: Merz Pharma GmbH & Co. KGaA
60318 Frankfurt am Main (DE)

(72) Inventors:
  • DANYSZ, Wojciech
    D-61130 Nidderau (DE)
  • DEKUNDY, Andrzej
    D-61137 Schöneck (DE)
  • HECHENBERGER, Mirko
    D-65193 Wiesbaden (DE)
  • HENRICH, Markus
    D-35516 Münzenberg (DE)
  • JATZKE, Claudia
    D-60433 Frankfurt/Main (DE)
  • NAGEL, Jens
    D-55442 Daxweiler (DE)
  • PARSONS, Christopher Graham Raphael
    D-61130 Nidderau (DE)
  • WEIL, Tanja
    D-60322 Frankfurt/Main (DE)
  • MÜLLER, Sybille
    D-55263 Wackernheim (DE)
  • FOTINS, Juris
    LV-2111 Kekavas nov. (LV)
  • GUTCAITS, Aleksandrs
    LV-1083 Riga (LV)
  • ZEMRIBO, Ronalds
    LV-2008 Jurmala (LV)
  • KAUSS, Valerjans
    LV-1082 Riga (LV)
  • KAULINA, Larisa
    LV-1003 Riga (LV)
  • ERDMANE, Elina
    LV-1019 Riga (LV)

(74) Representative: Jacobi, Markus Alexander 
Isenbruck Bösl Hörschler LLP Eastsite One Seckenheimer Landstrasse 4
68163 Mannheim
68163 Mannheim (DE)


(56) References cited: : 
WO-A-03/037900
US-A- 3 960 861
US-A- 4 717 724
 WO-A-2004/089471
US-A- 3 988 339
   
  • DATABASE CHEMCATS [Online] 1 January 2007 (2007-01-01), XP002460617 accession no. 2030376272 cited in the application
  • DATABASE REGISTRY [Online] 18 February 2005 (2005-02-18), XP002460618 Database accession no. RN:833441-66-0
  • DATABASE CHEMCATS 7 February 2006 (2006-02-07), XP002460619 accession no. 2021667751
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).